Literature DB >> 20167367

Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction.

L S Loubière1, E Vasilopoulou, J N Bulmer, P M Taylor, B Stieger, F Verrey, C J McCabe, J A Franklyn, M D Kilby, S-Y Chan.   

Abstract

Thyroid hormones (TH) are important for the development of the human fetus and placenta from very early gestation. The transplacental passage of TH from mother to fetus and the supply of TH into trophoblasts require the expression of placental TH plasma membrane transporters. We describe the ontogeny of the TH transporters MCT8, MCT10, LAT1, LAT2, OATP1A2 and OATP4A1 in a large series (n = 110) of normal human placentae across gestation and describe their expression changes with intrauterine fetal growth restriction (IUGR n = 22). Quantitative RT-PCR revealed that all the mRNAs encoding TH transporters are expressed in human placenta from 6 weeks gestation and throughout pregnancy. MCT8, MCT10, OATP1A2 and LAT1 mRNA expression increased with gestation. OATP4A1 and CD98 (LATs obligatory associated protein) mRNA expression reached a nadir in mid-gestation before increasing towards term. LAT2 mRNA expression did not alter throughout gestation. Immunohistochemistry localised MCT10 and OATP1A2 to villous cytotrophoblasts and syncytiotrophoblasts, and extravillous trophoblasts while OATP4A1 was preferentially expressed in the villous syncytiotrophoblasts. Whilst MCT8 protein expression was increased, MCT10 mRNA expression was decreased in placentae from IUGR pregnancies delivered in the early 3rd trimester compared to age matched appropriately grown for gestational age controls. No significant change was found in the mRNA expression of the other transporters with IUGR. In conclusion, several TH transporters are present in the human placenta from early 1st trimester with varying patterns of expression throughout gestation. Their coordinated effects may regulate both transplacental TH passage and TH supply to trophoblasts, which are critical for the normal development of the fetus and placenta. Increased MCT8 and decreased MCT10 expression within placentae of pregnancies complicated by IUGR may contribute to aberrant development of the fetoplacental unit. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167367     DOI: 10.1016/j.placenta.2010.01.013

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  28 in total

1.  PBDEs Concentrate in the Fetal Portion of the Placenta: Implications for Thyroid Hormone Dysregulation.

Authors:  Matthew T Ruis; Kylie D Rock; Samantha M Hall; Brian Horman; Heather B Patisaul; Heather M Stapleton
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

Review 2.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

Review 3.  Deciphering direct and indirect influence of thyroid hormone with mouse genetics.

Authors:  Frédéric Picou; Teddy Fauquier; Fabrice Chatonnet; Sabine Richard; Frédéric Flamant
Journal:  Mol Endocrinol       Date:  2014-03-10

4.  DNA methylation of amino acid transporter genes in the human placenta.

Authors:  C Simner; B Novakovic; K A Lillycrop; C G Bell; N C Harvey; C Cooper; R Saffery; R M Lewis; J K Cleal
Journal:  Placenta       Date:  2017-10-31       Impact factor: 3.481

5.  Facilitated transporters mediate net efflux of amino acids to the fetus across the basal membrane of the placental syncytiotrophoblast.

Authors:  J K Cleal; J D Glazier; G Ntani; S R Crozier; P E Day; N C Harvey; S M Robinson; C Cooper; K M Godfrey; M A Hanson; R M Lewis
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

Review 6.  The SLCO (former SLC21) superfamily of transporters.

Authors:  Bruno Hagenbuch; Bruno Stieger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

7.  Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters.

Authors:  Paul Berveiller; Olivier Mir; Séverine A Degrelle; Vassilis Tsatsaris; Lise Selleret; Jean Guibourdenche; Danièle Evain-Brion; Thierry Fournier; Sophie Gil
Journal:  Invest New Drugs       Date:  2018-10-26       Impact factor: 3.850

8.  The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation.

Authors:  S-Y Chan; A Martín-Santos; L S Loubière; A M González; B Stieger; A Logan; C J McCabe; J A Franklyn; M D Kilby
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

9.  Placental Inositol Reduced in Gestational Diabetes as Glucose Alters Inositol Transporters and IMPA1 Enzyme Expression.

Authors:  Reshma A Pillai; Mohammed O Islam; Preben Selvam; Neha Sharma; Anne H Y Chu; Oliver C Watkins; Keith M Godfrey; Rohan M Lewis; Shiao Y Chan
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

10.  Low oxygen tension differentially regulates the expression of placental solute carriers and ABC transporters.

Authors:  Ludwik Gorczyca; Jianyao Du; Kristin M Bircsak; Xia Wen; Anna M Vetrano; Lauren M Aleksunes
Journal:  FEBS Lett       Date:  2020-10-07       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.